External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ESOC 2023

-
Coming soon
10:57 AM
Duration 10mins Room 14 - Plenary
Efficacy and safety of tenecteplase in patients with late-window acute ischaemic stroke and evidence of salvageable tissue: Results from the Phase III TIMELESS trial
Gregory W. Albers

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar